• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Regulatory-grade device evidence reimagined with new precision data from Truveta

Regulatory-grade device evidence reimagined with new precision data from Truveta

by Ellie Lampton | Sep 23, 2025

Unique device identifier data linked with ADT and chargemaster data give medical device manufacturers unmatched visibility into device use, safety, and outcomes—accelerating regulatory submissions, discovering safety signals faster, and speeding innovation that shapes...
New study reveals shift in pediatric obesity treatment following AAP guidelines

New study reveals shift in pediatric obesity treatment following AAP guidelines

by Ellie Lampton | Jul 14, 2025

BELLEVUE, Wash.—July 14, 2025—A groundbreaking study published today in Pediatrics Open Science shows a notable increase in the use of medication to treat pediatric obesity in the United States following the 2023 release of comprehensive guidelines by the American...
A new era in cancer research: Truveta offers the most complete, representative, and timely real-world data on all cancers

A new era in cancer research: Truveta offers the most complete, representative, and timely real-world data on all cancers

by Ellie Lampton | May 8, 2025

BELLEVUE, Wash. – May 8, 2025 – Today, Truveta announced a new era in cancer research with more than 7 million oncology patient journeys spanning more than 100 cancer types, delivering an unprecedented breadth of regulatory grade data to support researchers in...
A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades

A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades

by Ellie Lampton | Apr 15, 2025

Published in the American Journal of Preventative Medicine, the new study shows that for the first time since its peak in 2022, syphilis incidence has declined, with larger decreases for men and young adults. BELLEVUE, WA — April 9, 2025 — A new study published in the...
New Truveta data and capabilities help researchers accelerate scientifically rigorous research

New Truveta data and capabilities help researchers accelerate scientifically rigorous research

by Ellie Lampton | Mar 26, 2025

BELLEVUE, Wash. – March 26, 2025 – Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. The company also announced two new Truveta Studio...
« Older Entries

Share this


Recent posts

  • Real-time monitoring of respiratory virus-associated hospitalizations: Trends through September 2025 
  • Exploring anemia burden and treatment patterns in patients with chronic kidney disease and diabetes
  • GLP-1 RA prescription trends: January 2018 – September 2025

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.